Targeting Tumor Immunosuppressive Microenvironment for the Prevention of Hepatic Cancer: Applications of Traditional Chinese Medicines in Targeted Delivery

Fitzmaurice, C.; Abate, D.; Abbasi, N.; Abbastabar, H.; Abd-Allah, F.; Abdel-Rahman, O.; Abdelalim, A.; Abdoli, A.; Abdollahpour, I.; Abdulle, A.S.M.; Abebe, N.D.; Abraha, H.N.; Abu-Raddad, L.J.; Abualhasan, A.; Adedeji, I.A.; Advani, S.M.; Afarideh, M.; Afshari, M.; Aghaali, M.; Agius, D.; Agrawal, S.; Ahmadi, A.; Ahmadian, E.; Ahmadpour, E.; Ahmed, M.B.; Akbari, M.E.; Akinyemiju, T.; Al-Aly, Z. AlAbdulKader, A.M.; Alahdab, F.; Alam, T.; Alamene, G.M.; Alemnew, B.T.T.; Alene, K.A.; Alinia, C.; Alipour, V.; Aljunid, S.M.; Bakeshei, F.A.; Almadi, M.A.H.; Almasi-Hashiani, A.; Alsharif, U.; Alsowaidi, S.; Alvis-Guzman, N.; Amini, E.; Amini, S.; Amoako, Y.A.; Anbari, Z.; Anber, N.H.; Andrei, C.L.; Anjomshoa, M.; Ansari, F.; Ansariadi, A.; Appiah, S.C.Y.; Arab-Zozani, M.; Arabloo, J.; Arefi, Z.; Aremu, O.; Areri, H.A.; Artaman, A.; Asayesh, H.; Asfaw, E.T.; Ashagre, A.F.; Assadi, R.; Ataeinia, B.; Atalay, H.T.; Ataro, Z.; Atique, S.; Ausloos, M.; Avila-Burgos, L.; Avokpaho, E.F.G.A.; Awasthi, A.; Awoke, N.; Ayala Quintanilla, B.P.; Ayanore, M.A.; Ayele, H.T.; Babaee, E.; Bacha, U.; Badawi, A.; Bagherzadeh, M.; Bagli, E.; Balakrishnan, S.; Balouchi, A.; Bärnighausen, T.W.; Battista, R.J.; Behzadifar, M.; Behzadifar, M.; Bekele, B.B.; Belay, Y.B.; Belayneh, Y.M.; Berfield, K.K.S.; Berhane, A.; Bernabe, E.; Beuran, M.; Bhakta, N.; Bhattacharyya, K.; Biadgo, B.; Bijani, A.; Bin Sayeed, M.S.; Birungi, C.; Bisignano, C.; Bitew, H.; Bjørge, T.; Bleyer, A.; Bogale, K.A.; Bojia, H.A.; Borzì, A.M.; Bosetti, C.; Bou-Orm, I.R.; Brenner, H.; Brewer, J.D.; Briko, A.N.; Briko, N.I.; Bustamante-Teixeira, M.T.; Butt, Z.A.; Carreras, G.; Carrero, J.J.; Carvalho, F.; Castro, C.; Castro, F.; Catalá-López, F.; Cerin, E.; Chaiah, Y.; Chanie, W.F.; Chattu, V.K.; Chaturvedi, P.; Chauhan, N.S.; Chehrazi, M.; Chiang, P.P.C.; Chichiabellu, T.Y.; Chido-Amajuoyi, O.G.; Chimed-Ochir, O.; Choi, J.J.; Christopher, D.J.; Chu, D.T.; Constantin, M.M.; Costa, V.M.; Crocetti, E.; Crowe, C.S.; Curado, M.P.; Dahlawi, S.M.A.; Damiani, G.; Darwish, A.H.; Daryani, A.; das Neves, J.; Demeke, F.M.; Demis, A.B.; Demissie, B.W.; Demoz, G.T.; Denova-Gutiérrez, E.; Derakhshani, A.; Deribe, K.S.; Desai, R.; Desalegn, B.B.; Desta, M.; Dey, S.; Dharmaratne, S.D.; Dhimal, M.; Diaz, D.; Dinberu, M.T.T.; Djalalinia, S.; Doku, D.T.; Drake, T.M.; Dubey, M.; Dubljanin, E.; Duken, E.E.; Ebrahimi, H.; Effiong, A.; Eftekhari, A.; El Sayed, I.; Zaki, M.E.S.; El-Jaafary, S.I.; El-Khatib, Z.; Elemineh, D.A.; Elkout, H.; Ellenbogen, R.G.; Elsharkawy, A.; Emamian, M.H.; Endalew, D.A.; Endries, A.Y.; Eshrati, B.; Fadhil, I.; Fallah Omrani, V.; Faramarzi, M.; Farhangi, M.A.; Farioli, A.; Farzadfar, F.; Fentahun, N.; Fernandes, E.; Feyissa, G.T.; Filip, I.; Fischer, F.; Fisher, J.L.; Force, L.M.; Foroutan, M.; Freitas, M.; Fukumoto, T.; Futran, N.D.; Gallus, S.; Gankpe, F.G.; Gayesa, R.T.; Gebrehiwot, T.T.; Gebremeskel, G.G.; Gedefaw, G.A.; Gelaw, B.K.; Geta, B.; Getachew, S.; Gezae, K.E.; Ghafourifard, M.; Ghajar, A.; Ghashghaee, A.; Gholamian, A.; Gill, P.S.; Ginindza, T.T.G.; Girmay, A.; Gizaw, M.; Gomez, R.S.; Gopalani, S.V.; Gorini, G.; Goulart, B.N.G.; Grada, A.; Ribeiro Guerra, M.; Guimaraes, A.L.S.; Gupta, P.C.; Gupta, R.; Hadkhale, K.; Haj-Mirzaian, A.; Haj-Mirzaian, A.; Hamadeh, R.R.; Hamidi, S.; Hanfore, L.K.; Haro, J.M.; Hasankhani, M.; Hasanzadeh, A.; Hassen, H.Y.; Hay, R.J.; Hay, S.I.; Henok, A.; Henry, N.J.; Herteliu, C.; Hidru, H.D.; Hoang, C.L.; Hole, M.K.; Hoogar, P.; Horita, N.; Hosgood, H.D.; Hosseini, M.; Hosseinzadeh, M.; Hostiuc, M.; Hostiuc, S.; Househ, M.; Hussen, M.M.; Ileanu, B.; Ilic, M.D.; Innos, K.; Irvani, S.S.N.; Iseh, K.R.; Islam, S.M.S.; Islami, F.; Jafari Balalami, N.; Jafarinia, M.; Jahangiry, L.; Jahani, M.A.; Jahanmehr, N.; Jakovljevic, M.; James, S.L.; Javanbakht, M.; Jayaraman, S.; Jee, S.H.; Jenabi, E.; Jha, R.P.; Jonas, J.B.; Jonnagaddala, J.; Joo, T.; Jungari, S.B.; Jürisson, M.; Kabir, A.; Kamangar, F.; Karch, A.; Karimi, N.; Karimian, A.; Kasaeian, A.; Kasahun, G.G.; Kassa, B.; Kassa, T.D.; Kassaw, M.W.; Kaul, A.; Keiyoro, P.N.; Kelbore, A.G.; Kerbo, A.A.; Khader, Y.S.; Khalilarjmandi, M.; Khan, E.A.; Khan, G.; Khang, Y.H.; Khatab, K.; Khater, A.; Khayamzadeh, M.; Khazaee-Pool, M.; Khazaei, S.; Khoja, A.T.; Khosravi, M.H.; Khubchandani, J.; Kianipour, N.; Kim, D.; Kim, Y.J.; Kisa, A.; Kisa, S.; Kissimova-Skarbek, K.; Komaki, H.; Koyanagi, A.; Krohn, K.J.; Bicer, B.K.; Kugbey, N.; Kumar, V.; Kuupiel, D.; La Vecchia, C.; Lad, D.P.; Lake, E.A.; Lakew, A.M.; Lal, D.K.; Lami, F.H.; Lan, Q.; Lasrado, S.; Lauriola, P.; Lazarus, J.V.; Leigh, J.; Leshargie, C.T.; Liao, Y.; Limenih, M.A.; Listl, S.; Lopez, A.D.; Lopukhov, P.D.; Lunevicius, R.; Madadin, M.; Magdeldin, S.; El Razek, H.M.A.; Majeed, A.; Maleki, A.; Malekzadeh, R.; Manafi, A.; Manafi, N.; Manamo, W.A.; Mansourian, M.; Mansournia, M.A.; Mantovani, L.G.; Maroufizadeh, S.; Martini, S.M.S.; Mashamba-Thompson, T.P.; Massenburg, B.B.; Maswabi, M.T.; Mathur, M.R.; McAlinden, C.; McKee, M.; Meheretu, H.A.A.; Mehrotra, R.; Mehta, V.; Meier, T.; Melaku, Y.A.; Meles, G.G.; Meles, H.G.; Melese, A.; Melku, M.; Memiah, P.T.N.; Mendoza, W.; Menezes, R.G.; Merat, S.; Meretoja, T.J.; Mestrovic, T.; Miazgowski, B.; Miazgowski, T.; Mihretie, K.M.M.; Miller, T.R.; Mills, E.J.; Mir, S.M.; Mirzaei, H.; Mirzaei, H.R.; Mishra, R.; Moazen, B.; Mohammad, D.K.; Mohammad, K.A.; Mohammad, Y.; Darwesh, A.M.; Mohammadbeigi, A.; Mohammadi, H.; Mohammadi, M.; Mohammadian, M.; Mohammadian-Hafshejani, A.; Mohammadoo-Khorasani, M.; Mohammadpourhodki, R.; Mohammed, A.S.; Mohammed, J.A.; Mohammed, S.; Mohebi, F.; Mokdad, A.H.; Monasta, L.; Moodley, Y.; Moosazadeh, M.; Moossavi, M.; Moradi, G.; Moradi-Joo, M.; Moradi-Lakeh, M.; Moradpour, F.; Morawska, L.; Morgado-da-Costa, J.; Morisaki, N.; Morrison, S.D.; Mosapour, A.; Mousavi, S.M.; Muche, A.A.; Muhammed, O.S.S.; Musa, J.; Nabhan, A.F.; Naderi, M.; Nagarajan, A.J.; Nagel, G.; Nahvijou, A.; Naik, G.; Najafi, F.; Naldi, L.; Nam, H.S.; Nasiri, N.; Nazari, J.; Negoi, I.; Neupane, S.; Newcomb, P.A.; Nggada, H.A.; Ngunjiri, J.W.; Nguyen, C.T.; Nikniaz, L.; Ningrum, D.N.A.; Nirayo, Y.L.; Nixon, M.R.; Nnaji, C.A.; Nojomi, M.; Nosratnejad, S.; Shiadeh, M.N.; Obsa, M.S.; Ofori-Asenso, R.; Ogbo, F.A.; Oh, I.H.; Olagunju, A.T.; Olagunju, T.O.; Oluwasanu, M.M.; Omonisi, A.E.; Onwujekwe, O.E.; Oommen, A.M.; Oren, E.; Ortega-Altamirano, D.D.V.; Ota, E.; Otstavnov, S.S.; Owolabi, M.O.; P A, M.; Padubidri, J.R.; Pakhale, S.; Pakpour, A.H.; Pana, A.; Park, E.K.; Parsian, H.; Pashaei, T.; Patel, S.; Patil, S.T.; Pennini, A.; Pereira, D.M.; Piccinelli, C.; Pillay, J.D.; Pirestani, M.; Pishgar, F.; Postma, M.J.; Pourjafar, H.; Pourmalek, F.; Pourshams, A.; Prakash, S.; Prasad, N.; Qorbani, M.; Rabiee, M.; Rabiee, N.; Radfar, A.; Rafiei, A.; Rahim, F.; Rahimi, M.; Rahman, M.A.; Rajati, F.; Rana, S.M.; Raoofi, S.; Rath, G.K.; Rawaf, D.L.; Rawaf, S.; Reiner, R.C.; Renzaho, A.M.N.; Rezaei, N.; Rezapour, A.; Ribeiro, A.I.; Ribeiro, D.; Ronfani, L.; Roro, E.M.; Roshandel, G.; Rostami, A.; Saad, R.S.; Sabbagh, P.; Sabour, S.; Saddik, B.; Safiri, S.; Sahebkar, A.; Salahshoor, M.R.; Salehi, F.; Salem, H.; Salem, M.R.; Salimzadeh, H.; Salomon, J.A.; Samy, A.M.; Sanabria, J.; Santric Milicevic, M.M.; Sartorius, B.; Sarveazad, A.; Sathian, B.; Satpathy, M.; Savic, M.; Sawhney, M.; Sayyah, M.; Schneider, I.J.C.; Schöttker, B.; Sekerija, M.; Sepanlou, S.G.; Sepehrimanesh, M.; Seyedmousavi, S.; Shaahmadi, F.; Shabaninejad, H.; Shahbaz, M.; Shaikh, M.A.; Shamshirian, A.; Shamsizadeh, M.; Sharafi, H.; Sharafi, Z.; Sharif, M.; Sharifi, A.; Sharifi, H.; Sharma, R.; Sheikh, A.; Shirkoohi, R.; Shukla, S.R.; Si, S.; Siabani, S.; Silva, D.A.S.; Silveira, D.G.A.; Singh, A.; Singh, J.A.; Sisay, S.; Sitas, F.; Sobngwi, E.; Soofi, M.; Soriano, J.B.; Stathopoulou, V.; Sufiyan, M.B.; Tabarés-Seisdedos, R.; Tabuchi, T.; Takahashi, K.; Tamtaji, O.R.; Tarawneh, M.R.; Tassew, S.G.; Taymoori, P.; Tehrani-Banihashemi, A.; Temsah, M.H.; Temsah, O.; Tesfay, B.E.; Tesfay, F.H.; Teshale, M.Y.; Tessema, G.A.; Thapa, S.; Tlaye, K.G.; Topor-Madry, R.; Tovani-Palone, M.R.; Traini, E.; Tran, B.X.; Tran, K.B.; Tsadik, A.G.; Ullah, I.; Uthman, O.A.; Vacante, M.; Vaezi, M.; Varona Pérez, P.; Veisani, Y.; Vidale, S.; Violante, F.S.; Vlassov, V.; Vollset, S.E.; Vos, T.; Vosoughi, K.; Vu, G.T.; Vujcic, I.S.; Wabinga, H.; Wachamo, T.M.; Wagnew, F.S.; Waheed, Y.; Weldegebreal, F.; Weldesamuel, G.T.; Wijeratne, T.; Wondafrash, D.Z.; Wonde, T.E.; Wondmieneh, A.B.; Workie, H.M.; Yadav, R.; Yadegar, A.; Yadollahpour, A.; Yaseri, M.; Yazdi-Feyzabadi, V.; Yeshaneh, A.; Yimam, M.A.; Yimer, E.M.; Yisma, E.; Yonemoto, N.; Younis, M.Z.; Yousefi, B.; Yousefifard, M.; Yu, C.; Zabeh, E.; Zadnik, V.; Moghadam, T.Z.; Zaidi, Z.; Zamani, M.; Zandian, H.; Zangeneh, A.; Zaki, L.; Zendehdel, K.; Zenebe, Z.M.; Zewale, T.A.; Ziapour, A.; Zodpey, S.; Murray, C.J.L. Global burden of disease cancer collaboration. global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol., 2019, 5(12), 1749-1768.
[http://dx.doi.org/10.1001/jamaoncol.2019.2996] [PMID: 31560378]

Singh, A.K.; Kumar, R.; Pandey, A.K. Hepatocellular carcinoma: causes, mechanism of progression and biomarkers. Curr. Chem. Genomics Transl. Med., 2018, 12, 9-26.
[http://dx.doi.org/10.2174/2213988501812010009] [PMID: 30069430]

Ferlay, J.; Soerjomataram, I.; Dikshit, R.; Eser, S.; Mathers, C.; Rebelo, M.; Parkin, D.M.; Forman, D.; Bray, F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer, 2015, 136(5), E359-E386.
[http://dx.doi.org/10.1002/ijc.29210] [PMID: 25220842]

Zamor, P.J.; deLemos, A.S.; Russo, M.W. Viral hepatitis and hepatocellular carcinoma: etiology and management. J. Gastrointest. Oncol., 2017, 8(2), 229-242.
[http://dx.doi.org/10.21037/jgo.2017.03.14] [PMID: 28480063]

Stanaway, J.D.; Flaxman, A.D.; Naghavi, M.; Fitzmaurice, C.; Vos, T.; Abubakar, I.; Abu-Raddad, L.J.; Assadi, R.; Bhala, N.; Cowie, B.; Forouzanfour, M.H.; Groeger, J.; Hanafiah, K.M.; Jacobsen, K.H.; James, S.L.; MacLachlan, J.; Malekzadeh, R.; Martin, N.K.; Mokdad, A.A.; Mokdad, A.H.; Murray, C.J.L.; Plass, D.; Rana, S.; Rein, D.B.; Richardus, J.H.; Sanabria, J.; Saylan, M.; Shahraz, S.; So, S.; Vlassov, V.V.; Weiderpass, E.; Wiersma, S.T.; Younis, M.; Yu, C.; El Sayed Zaki, M.; Cooke, G.S. The global burden of viral hepatitis from 1990 to 2013: findings from the global burden of disease study 2013. Lancet, 2016, 388(10049), 1081-1088.
[http://dx.doi.org/10.1016/S0140-6736(16)30579-7] [PMID: 27394647]

Tahmasebi Birgani, M.; Carloni, V. Tumor microenvironment, a paradigm in hepatocellular carcinoma progression and therapy. Int. J. Mol. Sci., 2017, 18(2), 18.
[http://dx.doi.org/10.3390/ijms18020405] [PMID: 28216578]

Adams, J.M.; Cory, S. The BCL-2 arbiters of apoptosis and their growing role as cancer targets. Cell Death Differ., 2018, 25(1), 27-36.
[http://dx.doi.org/10.1038/cdd.2017.161] [PMID: 29099483]

Weyandt, J.D.; Thompson, C.B.; Giaccia, A.J.; Rathmell, W.K. Metabolic alterations in cancer and their potential as therapeutic targets. Am. Soc. Clin. Oncol. Educ. Book, 2017, 37, 825-832.
[http://dx.doi.org/10.14694/EDBK_175561] [PMID: 28561705]

Wu, Q.; Zhou, L.; Lv, D.; Zhu, X.; Tang, H. Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression. J. Hematol. Oncol., 2019, 12(1), 53.
[http://dx.doi.org/10.1186/s13045-019-0739-0] [PMID: 31142326]

Yang, J.D.; Nakamura, I.; Roberts, L.R. The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets. Semin. Cancer Biol., 2011, 21(1), 35-43.
[http://dx.doi.org/10.1016/j.semcancer.2010.10.007] [PMID: 20946957]

Roma-Rodrigues, C.; Mendes, R.; Baptista, P.V.; Fernandes, A.R. Targeting tumor microenvironment for cancer therapy. Int. J. Mol. Sci., 2019, 20(4), 20.
[http://dx.doi.org/10.3390/ijms20040840] [PMID: 30781344]

Seretis, F.; Seretis, C.; Youssef, H.; Chapman, M. Colorectal cancer: seed and soil hypothesis revisited. Anticancer Res., 2014, 34(5), 2087-2094.
[PMID: 24778010]

Husori, D.I.; Patilaya, P.; Sumantri, I.B.; Khaisar, N.E. Acute toxicity studies of acanthus illicifolius leaves ethanolic extract on male mice. Drug Invent. Today, 2018, 10, 2507-2513.

Philip, J.M.; Rebecca, L.J.; Abraham, H.M.; Venkatakrishnan, C.J.; Chandran, C.R. Anbuselvi. antibacterial activity of phytochemicals against oral bacteria. Drug Invent. Today, 2018, 10, 1091-1093.

Mustarichie, R.; Udin, L.Z. In Vitro Anticancer activity of extract fractions resulted from fermented endophytic fungi on taxus sumatrana. Drug Invent. Today, 2018, 10, 443-449.

Nikakhlagh, S.; Rahim, F.; Aryani, F.H.N.; Syahpoush, A.; Brougerdnya, M.G.; Saki, N. Herbal treatment of allergic rhinitis: the use of nigella sativa. Am. J. Otolaryngol., 2011, 32(5), 402-407.
[http://dx.doi.org/10.1016/j.amjoto.2010.07.019] [PMID: 20947211]

Kishore, M.; Abdulqader, A.T.; Shihab Ahmad, H.; Hanumantharao, Y. Anticancer and antibacterial potential of green silver nanoparticles synthesized from maytenus senegalensis (l.) leaf extract and their characterization. Drug Invent. Today, 2018, 10, 554-561.

Paul, R.; Geetha, R.V. Evaluation of anti-inflammatory action of illicium verum - an in vitro study. Drug Invent. Today, 2018, 10, 2441-2444.

Xu, J.; Song, Z.; Guo, Q.; Li, J. Synergistic effect and molecular mechanisms of traditional chinese medicine on regulating tumor microenvironment and cancer cells. Bio med Res. Int., 2016, 2016, 1490738.

Laplagne, C.; Domagala, M.; Le Naour, A.; Quemerais, C.; Hamel, D.; Fournié, J.J.; Couderc, B.; Bousquet, C.; Ferrand, A.; Poupot, M. Latest advances in targeting the tumor microenvironment for tumor suppression. Int. J. Mol. Sci., 2019, 20(19), 20.
[http://dx.doi.org/10.3390/ijms20194719] [PMID: 31547627]

Maimela, N.R.; Liu, S.; Zhang, Y. Fates of CD8+ T cells in Tumor Microenvironment. Comput. Struct. Biotechnol. J., 2018, 17, 1-13.
[http://dx.doi.org/10.1016/j.csbj.2018.11.004] [PMID: 30581539]

Hong, M.; Wang, N.; Feng, Y. Liver cancer treatment by chinese medicines and their active compounds. In: Anti-cancer Drugs - Nature, Synthesis and Cell; InTech: London; , 2016.
[http://dx.doi.org/10.5772/65319]

Balkwill, F.R.; Capasso, M.; Hagemann, T. The tumor microenvironment at a glance. J. Cell Sci., 2012, 125(Pt 23), 5591-5596.
[http://dx.doi.org/10.1242/jcs.116392] [PMID: 23420197]

Ostroumov, D.; Fekete-Drimusz, N.; Saborowski, M.; Kühnel, F.; Woller, N. CD4 and CD8 T lymphocyte interplay in controlling tumor growth. Cell. Mol. Life Sci., 2018, 75(4), 689-713.
[http://dx.doi.org/10.1007/s00018-017-2686-7] [PMID: 29032503]

Farhood, B.; Najafi, M.; Mortezaee, K. CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review. J. Cell. Physiol., 2019, 234(6), 8509-8521.
[http://dx.doi.org/10.1002/jcp.27782] [PMID: 30520029]

van Dalen, F.J.; van Stevendaal, M.H.M.E.; Fennemann, F.L.; Verdoes, M.; Ilina, O. Molecular repolarisation of tumour-associated macrophages. Molecules, 2018, 24(1), 24.
[http://dx.doi.org/10.3390/molecules24010009] [PMID: 30577495]

Bhome, R.; Bullock, M.D.; Al Saihati, H.A.; Goh, R.W.; Primrose, J.N.; Sayan, A.E.; Mirnezami, A.H. A top-down view of the tumor microenvironment: structure, cells and signaling. Front. Cell Dev. Biol., 2015, 3, 33.
[http://dx.doi.org/10.3389/fcell.2015.00033] [PMID: 26075202]

Ries, C.H.; Cannarile, M.A.; Hoves, S.; Benz, J.; Wartha, K.; Runza, V.; Rey-Giraud, F.; Pradel, L.P.; Feuerhake, F.; Klaman, I.; Jones, T.; Jucknischke, U.; Scheiblich, S.; Kaluza, K.; Gorr, I.H.; Walz, A.; Abiraj, K.; Cassier, P.A.; Sica, A.; Gomez-Roca, C.; de Visser, K.E.; Italiano, A.; Le Tourneau, C.; Delord, J.P.; Levitsky, H.; Blay, J.Y.; Rüttinger, D. Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy. Cancer Cell, 2014, 25(6), 846-859.
[http://dx.doi.org/10.1016/j.ccr.2014.05.016] [PMID: 24898549]

Malfitano, A.M.; Somma, S.D.; Prevete, N.; Portella, G. Virotherapy as a potential therapeutic approach for the treatment of aggressive thyroid cancer. Cancers (Basel), 2019, 11(10), 11.
[http://dx.doi.org/10.3390/cancers11101532] [PMID: 31636245]

Zhou, M.; Wen, K.; Bi, Y.; Lu, H.; Chen, J.; Hu, Y.; Chai, Z. The application of stimuli-responsive nanocarriers for targeted drug delivery. Curr. Top. Med. Chem., 2017, 17(20), 2319-2334.
[http://dx.doi.org/10.2174/1568026617666170224121008] [PMID: 28240179]

Bovy, N.; Blomme, B.; Frères, P.; Dederen, S.; Nivelles, O.; Lion, M.; Carnet, O.; Martial, J.A.; Noël, A.; Thiry, M.; Jérusalem, G.; Josse, C.; Bours, V.; Tabruyn, S.P.; Struman, I. Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer. Oncotarget, 2015, 6(12), 10253-10266.
[http://dx.doi.org/10.18632/oncotarget.3520] [PMID: 25860935]

Barbouri, D.; Afratis, N.; Gialeli, C.; Vynios, D.H.; Theocharis, A.D.; Karamanos, N.K. Syndecans as modulators and potential pharmacological targets in cancer progression. Front. Oncol., 2014, 4, 4.
[http://dx.doi.org/10.3389/fonc.2014.00004] [PMID: 24551591]

Steichen, S.D.; Caldorera-Moore, M.; Peppas, N.A. A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics. Eur. J. Pharm. Sci., 2013, 48(3), 416-427.
[http://dx.doi.org/10.1016/j.ejps.2012.12.006] [PMID: 23262059]

Giraldo, N.A.; Sanchez-Salas, R.; Peske, J.D.; Vano, Y.; Becht, E.; Petitprez, F.; Validire, P.; Ingels, A.; Cathelineau, X.; Fridman, W.H.; Sautès-Fridman, C. The clinical role of the TME in solid cancer. Br. J. Cancer, 2019, 120(1), 45-53.
[http://dx.doi.org/10.1038/s41416-018-0327-z] [PMID: 30413828]

Ma, L.; Hernandez, M.O.; Zhao, Y.; Mehta, M.; Tran, B.; Kelly, M.; Rae, Z.; Hernandez, J.M.; Davis, J.L.; Martin, S.P.; Kleiner, D.E.; Hewitt, S.M.; Ylaya, K.; Wood, B.J.; Greten, T.F.; Wang, X.W. Tumor cell biodiversity drives microenvironmental reprogramming in liver cancer. Cancer Cell, 2019, 36(4), 418-430.e6.
[http://dx.doi.org/10.1016/j.ccell.2019.08.007] [PMID: 31588021]

Zhang, Q.; Lou, Y.; Bai, X.L.; Liang, T.B. Immunometabolism: A novel perspective of liver cancer microenvironment and its influence on tumor progression. World J. Gastroenterol., 2018, 24(31), 3500-3512.
[http://dx.doi.org/10.3748/wjg.v24.i31.3500] [PMID: 30131656]

Lawless, S.J.; Kedia-Mehta, N.; Walls, J.F.; McGarrigle, R.; Convery, O.; Sinclair, L.V.; Navarro, M.N.; Murray, J.; Finlay, D.K. Glucose represses dendritic cell-induced T cell responses. Nat. Commun., 2017, 8, 15620.
[http://dx.doi.org/10.1038/ncomms15620] [PMID: 28555668]

Yaqoob, P. Fatty acids as gatekeepers of immune cell regulation. Trends Immunol., 2003, 24(12), 639-645.
[http://dx.doi.org/10.1016/j.it.2003.10.002] [PMID: 14644137]

Fang, M.; Yuan, J.; Chen, M.; Sun, Z.; Liu, L.; Cheng, G.; Ying, H.; Yang, S.; Chen, M. The heterogenic tumor microenvironment of hepatocellular carcinoma and prognostic analysis based on tumor neo-vessels, macrophages and α-SMA. Oncol. Lett., 2018, 15(4), 4805-4812.
[http://dx.doi.org/10.3892/ol.2018.7946] [PMID: 29552120]

Nishida, N.; Kudo, M. Oncogenic signal and tumor microenvironment in hepatocellular carcinoma. Oncology, 2017, 93(Suppl. 1), 160-164.
[http://dx.doi.org/10.1159/000481246] [PMID: 29258072]

Liu, J.; Wang, S.; Zhang, Y.; Fan, H.T.; Lin, H.S. Traditional Chinese medicine and cancer: History, present situation, and development. Thorac. Cancer, 2015, 6(5), 561-569.
[http://dx.doi.org/10.1111/1759-7714.12270] [PMID: 26445604]

Lin, W.F.; Lu, J.Y.; Cheng, B.B.; Ling, C.Q. Progress in research on the effects of traditional Chinese medicine on the tumor microenvironment. J. Integr. Med., 2017, 15(4), 282-287.
[http://dx.doi.org/10.1016/S2095-4964(17)60345-5] [PMID: 28659232]

Yin, S.Y.; Wei, W.C.; Jian, F.Y.; Yang, N.S. Therapeutic applications of herbal medicines for cancer patients. Evidence-based Complementary and Alternative Medicine, 2013., 302426. (In press)
[http://dx.doi.org/10.1155/2013/302426]

Nie, J.; Zhao, C.; Deng, L.I.; Chen, J.; Yu, B.; Wu, X.; Pang, P.; Chen, X. Efficacy of traditional Chinese medicine in treating cancer. Biomed. Rep., 2016, 4(1), 3-14.
[http://dx.doi.org/10.3892/br.2015.537] [PMID: 26870326]

Nathanael, L. Guang-Biab. Zhou; Bhavana, Prasher; Mitali, Mukerji;Zhu, Chen; Samir, Brahamachari; Noble, Denis; Auffray Charles; Sagner, M. Traditional knowledge-based medicine: a review of history: progress in preventive medicine. Prog. Prev. Med., 2017, 2, e0011.

Liao, X.; Bu, Y.; Jia, Q. Traditional Chinese medicine as supportive care for the management of liver cancer: Past, present, and future. Genes Dis., 2019, 7(3), 370-379.
[http://dx.doi.org/10.1016/j.gendis.2019.10.016] [PMID: 32884991]

Guan, Y.; He, Q. Liver Cancer: Zheng Classification of Qi Stagnation and Blood Stasis. Pharmacol. & Amp. Pharm., 2014, 05, 75-82.

Chen, Z.; Chen, L.Y.; Wang, P.; Dai, H.Y.; Gao, S.; Wang, K. Tumor microenvironment varies under different tcm zheng models and correlates with treatment response to herbal medicine. Evidence-based Complement. Altern. Med, 2012, 2012(6), 635702.

Ling, C. quan; Fan, J.; Lin, H. sheng; Shen, F.; Xu, Z. ye; Lin, L. zhu; Qin, S. kui; Zhou, W. ping; Zhai, X. feng; Li, B.; Zhou, Q. hui. Clinical practice guidelines for the treatment of primary liver cancer with integrative traditional chinese and western medicine. J. Integr. Med., 2018, 16, 236-248.
[http://dx.doi.org/10.1016/j.joim.2018.05.002] [PMID: 29891180]

Yadollahpour, A. Magnetic nanoparticles in medicine: a review of synthesis methods and important characteristics. Orient. J. Chem., 2015, 31, 271-277.
[http://dx.doi.org/10.13005/ojc/31.Special-Issue1.33]

Yadollahpour, A.; Hosseini, S.A.A.; Jalilifar, M.; Rashidi, S.; Rai, B.M.M. Magnetic nanoparticle-based drug and gene delivery: a review of recent advances and clinical applications. Int. J. Pharm. Technol., 2016, 8, 11451-11466.

Sweetha, G.; Abraham, A.; Dhanraj, M.; Jain, A.R. Fabrication and evaluation of polylactic acid membrane for drug delivery system. Drug Invent. Today, 2018, 10, 433-436.

Lin, N.; Zhang, Y.; Mao, X. Application and perspectives of traditional chinese medicine in the treatment of liver cancer. Cancer Transl. Med., 2015, 1, 101.
[http://dx.doi.org/10.4103/2395-3977.159538]

Yang, Z.; Liao, X.; Lu, Y.; Xu, Q.; Tang, B.; Chen, X.; Yu, Y. Add-on therapy with traditional chinese medicine improves outcomes and reduces adverse events in hepatocellular carcinoma: a meta-analysis of randomized controlled trials. Evidence-based Complementary and Alternative Medicine, 2017, 2017, 3428253.
[http://dx.doi.org/10.1155/2017/3428253]

Wu, R.; Ru, Q.; Chen, L.; Ma, B.; Li, C. Stereospecificity of ginsenoside Rg3 in the promotion of cellular immunity in hepatoma H22-bearing mice. J. Food Sci., 2014, 79(7), H1430-H1435.
[http://dx.doi.org/10.1111/1750-3841.12518] [PMID: 25041540]

Nicholson, S.E.; Keating, N.; Belz, G.T. Natural killer cells and anti-tumor immunity. Mol. Immunol., 2019, 110, 40-47.
[http://dx.doi.org/10.1016/j.molimm.2017.12.002] [PMID: 29233542]

Lee, J.; Lee, S.J.; Lim, K.T. ZPDC glycoprotein (24 kDa) induces apoptosis and enhances activity of NK cells in N-nitrosodiethylamine-injected Balb/c. Cell. Immunol., 2014, 289(1-2), 1-6.
[http://dx.doi.org/10.1016/j.cellimm.2014.03.002] [PMID: 24681514]

Wong, C.; Goldstein, D.R. Impact of aging on antigen presentation cell function of dendritic cells. Curr. Opin. Immunol., 2013, 25(4), 535-541.
[http://dx.doi.org/10.1016/j.coi.2013.05.016] [PMID: 23806201]

Takei, M.; Tachikawa, E.; Umeyama, A. Dendritic cells promoted by ginseng saponins drive a potent th1 polarization. Biomark. Insights, 2008, 3, 269-286.
[http://dx.doi.org/10.4137/BMI.S585]

Terhune, J.; Berk, E.; Czerniecki, B.J. Dendritic cell-induced th1 and th17 cell differentiation for cancer therapy. Vaccines (Basel), 2013, 1(4), 527-549.
[http://dx.doi.org/10.3390/vaccines1040527] [PMID: 26344346]

Ni, L.; Lu, J. Interferon gamma in cancer immunotherapy. Cancer Med., 2018, 7(9), 4509-4516.
[http://dx.doi.org/10.1002/cam4.1700] [PMID: 30039553]

Salimian Rizi, B.; Achreja, A.; Nagrath, D. Nitric oxide: the forgotten child of tumor metabolism. Trends Cancer, 2017, 3(9), 659-672.
[http://dx.doi.org/10.1016/j.trecan.2017.07.005] [PMID: 28867169]

Li, Z.; Hao, H.; Tian, W.; Jiao, Y.; Deng, X.; Han, S.; Han, J. Nitric oxide, a communicator between tumor cells and endothelial cells, mediates the anti-tumor effects of Marsdenia Tenacissima Extract (MTE). J. Ethnopharmacol., 2020, 250, 112524.
[http://dx.doi.org/10.1016/j.jep.2019.112524] [PMID: 31884032]

Yu, D.; An, G.Y. Clinical effects of xihuang pill combined with chemotherapy in patients with advanced colorectal cancer. Evidence-based Complement. Altern. Med, 2017, 2017, 5936086.

Su, L.; Jiang, Y.; Xu, Y.; Li, X.; Gao, W.; Xu, C.; Zeng, C.; Song, J.; Weng, W.; Liang, W. Xihuang pill promotes apoptosis of Treg cells in the tumor microenvironment in 4T1 mouse breast cancer by upregulating MEKK1/SEK1/JNK1/AP-1 pathway. Biomed. Pharmacother., 2018, 102, 1111-1119.
[http://dx.doi.org/10.1016/j.biopha.2018.03.063] [PMID: 29710529]

Fan, Y.; Li, S.; Ding, X.; Yue, J.; Jiang, J.; Zhao, H.; Hao, R.; Qiu, W.; Liu, K.; Li, Y.; Wang, S.; Zheng, L.; Ye, B.; Meng, K.; Xu, B. First-in-class immune-modulating small molecule Icaritin in advanced hepatocellular carcinoma: preliminary results of safety, durable survival and immune biomarkers. BMC Cancer, 2019, 19(1), 279.
[http://dx.doi.org/10.1186/s12885-019-5471-1] [PMID: 30922248]

Li, W.; Wang, M.; Wang, L.; Ji, S.; Zhang, J.; Zhang, C. Icariin synergizes with arsenic trioxide to suppress human hepatocellular carcinoma. Cell Biochem. Biophys., 2014, 68(2), 427-436.
[http://dx.doi.org/10.1007/s12013-013-9724-3] [PMID: 23975599]

Ma, Y.; Feng, C.; Wang, J.; Chen, Z.; Wei, P.; Fan, A.; Wang, X.; Yu, X.; Ge, D.; Xie, H.; Liu, L.; Zhang, Q.; Li, X.H. Hydroxyl safflower yellow A regulates the tumor immune microenvironment to produce an anticancer effect in a mouse model of hepatocellular carcinoma. Oncol. Lett., 2019, 17(3), 3503-3510.
[http://dx.doi.org/10.3892/ol.2019.9946] [PMID: 30867790]

Jiang, Y.X.; Chen, Y.; Yang, Y.; Chen, X.X.; Zhang, D.D.Y.X. Screening five qi-tonifying herbs on m2 phenotype macrophages. Evid. Based Complement. Alternat. Med., 2019, 2019, 9549315-9549315.
[http://dx.doi.org/10.1155/2019/9549315] [PMID: 30766614]

Brown, J.M.; Recht, L.; Strober, S. The promise of targeting macrophages in cancer therapy. Clin. Cancer Res., 2017, 23(13), 3241-3250.
[http://dx.doi.org/10.1158/1078-0432.CCR-16-3122] [PMID: 28341752]

Li, A.; Shuai, X.; Jia, Z.; Li, H.; Liang, X.; Su, D.; Guo, W. Ganoderma lucidum polysaccharide extract inhibits hepatocellular carcinoma growth by downregulating regulatory T cells accumulation and function by inducing microRNA-125b. J. Transl. Med., 2015, 13, 100.
[http://dx.doi.org/10.1186/s12967-015-0465-5] [PMID: 25889022]

Jing, Y.; Han, Z.; Zhang, S.; Liu, Y.; Wei, L. Epithelial-mesenchymal transition in tumor microenvironment. Cell Biosci., 2011, 1, 29.
[http://dx.doi.org/10.1186/2045-3701-1-29] [PMID: 21880137]

Condeelis, J.; Segall, J.E. Intravital imaging of cell movement in tumours. Nat. Rev. Cancer, 2003, 3(12), 921-930.
[http://dx.doi.org/10.1038/nrc1231] [PMID: 14737122]

Liang, S.; Zou, Y.; Gao, J.; Liu, X.; Lin, W.; Yin, Z.; Du, J.; Zhang, Y.; Chen, Q.; Li, S.; Cheng, B.; Ling, C. The chinese medicine, jiedu recipe, inhibits the epithelial mesenchymal transition of hepatocellular carcinoma via the regulation of smad2/3 dependent and independent pathways. Evid. Based Complement. Alternat. Med., 2018, 2018, 5629304.

Hu, S.; Zhu, Y.; Xia, X.; Xu, X.; Chen, F.; Miao, X.; Chen, X. Ginsenoside rg3 prolongs survival of the orthotopic hepatocellular carcinoma model by inducing apoptosis and inhibiting angiogenesis. Anal. Cell. Pathol., 2019. (In press)
[http://dx.doi.org/10.1155/2019/3815786]

Lu, Z.; Chang, L.; Zhou, H.; Liu, X.; Li, Y.; Mi, T.; Tong, D. Arctigenin attenuates tumor metastasis through inhibiting epithelial-mesenchymal transition in hepatocellular carcinoma via suppressing gsk3β-dependent wnt/β-catenin signaling pathway in vivo and in vitro. Front. Pharmacol., 2019, 10, 937.

Nallanthighal, S.; Heiserman, J.P.; Cheon, D-J. The role of the extracellular matrix in cancer stemness. Front. Cell Dev. Biol., 2019, 7, 86.
[http://dx.doi.org/10.3389/fcell.2019.00086] [PMID: 31334229]

Song, J.; Ge, Z.; Yang, X.; Luo, Q.; Wang, C.; You, H.; Ge, T.; Deng, Y.; Lin, H.; Cui, Y.; Chu, W.; Yao, M.; Zhang, Z.; Gu, J.; Fan, J.; Qin, W. Hepatic stellate cells activated by acidic tumor microenvironment promote the metastasis of hepatocellular carcinoma via osteopontin. Cancer Lett., 2015, 356(2 Pt B), 713-720.
[http://dx.doi.org/10.1016/j.canlet.2014.10.021] [PMID: 25449435]

Wright, J.H.; Johnson, M.M.; Shimizu-Albergine, M.; Bauer, R.L.; Hayes, B.J.; Surapisitchat, J.; Hudkins, K.L.; Riehle, K.J.; Johnson, S.C.; Yeh, M.M.; Bammler, T.K.; Beyer, R.P.; Gilbertson, D.G.; Alpers, C.E.; Fausto, N.; Campbell, J.S. Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: evidence for stromal induction of hepatocellular carcinoma. Int. J. Cancer, 2014, 134(4), 778-788.
[http://dx.doi.org/10.1002/ijc.28421] [PMID: 23929039]

Liotta, L.A. Adhere, degrade, and move: the three-step model of invasion. Cancer Res., 2016, 76(11), 3115-3117.
[http://dx.doi.org/10.1158/0008-5472.CAN-16-1297] [PMID: 27251085]

Deng, W.; Sui, H.; Wang, Q.; He, N.; Duan, C.; Han, L.; Li, Q.; Lu, M.; Lv, S. A Chinese herbal formula, Yi-Qi-Fu-Sheng, inhibits migration/invasion of colorectal cancer by down-regulating MMP-2/9 via inhibiting the activation of ERK/MAPK signaling pathways. BMC Complement. Altern. Med., 2013, 13, 65.
[http://dx.doi.org/10.1186/1472-6882-13-65] [PMID: 23506655]

Wang, Y.; Zhang, S.; Liu, J.; Fang, B.; Yao, J.; Cheng, B. Matrine inhibits the invasive and migratory properties of human hepatocellular carcinoma by regulating epithelial mesenchymal transition. Mol. Med. Rep., 2018, 18(1), 911-919.
[http://dx.doi.org/10.3892/mmr.2018.9023] [PMID: 29845189]

Pang, D.; Yang, C.; Li, C.; Zou, Y.; Feng, B.; Li, L.; Liu, W.; Luo, Q.; Chen, Z.; Huang, C.; Polyphyllin, I.I. Inhibits liver cancer cell proliferation, migration and invasion through downregulated cofilin activity and the akt/nf-kb pathway. Biol. Open, 2020, 9(2), bio046854.

Morse, M.A.; Sun, W.; Kim, R.; He, A.R.; Abada, P.B.; Mynderse, M.; Finn, R.S. The role of angiogenesis in hepatocellular carcinoma. Clin. Cancer Res., 2019, 25(3), 912-920.
[http://dx.doi.org/10.1158/1078-0432.CCR-18-1254] [PMID: 30274981]

Muz, B.; de la Puente, P.; Azab, F.; Azab, A.K. The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia (Auckl.), 2015, 3, 83-92.
[http://dx.doi.org/10.2147/HP.S93413] [PMID: 27774485]

Katayama, Y.; Uchino, J.; Chihara, Y.; Tamiya, N.; Kaneko, Y.; Yamada, T.; Takayama, K. Tumor neovascularization and developments in therapeutics. Cancers (Basel), 2019, 11(3), 11.
[http://dx.doi.org/10.3390/cancers11030316] [PMID: 30845711]

Rajabi, M.; Mousa, S.A. The role of angiogenesis in cancer treatment. Biomedicines, 2017, 5(2), 5.
[http://dx.doi.org/10.3390/biomedicines5020034] [PMID: 28635679]

Yang, F.; Li, J.; Zhu, J.; Wang, D.; Chen, S.; Bai, X. Hydroxysafflor yellow A inhibits angiogenesis of hepatocellular carcinoma via blocking ERK/MAPK and NF-κB signaling pathway in H22 tumor-bearing mice. Eur. J. Pharmacol., 2015, 754, 105-114.
[http://dx.doi.org/10.1016/j.ejphar.2015.02.015] [PMID: 25720342]

Xie, T.X.; Xia, Z.; Zhang, N.; Gong, W.; Huang, S. Constitutive NF-kappaB activity regulates the expression of VEGF and IL-8 and tumor angiogenesis of human glioblastoma. Oncol. Rep., 2010, 23(3), 725-732.
[PMID: 20127012]

Zhou, Y.; Liu, Y.; Chen, J.; Sun, Y.Z.; Li, L.H.; Chen, L. Inhibition of β-elemene on the expressions of HIF-lα, VEGF and iNOS in diabetic rats model. Int. J. Ophthalmol., 2019, 12(11), 1693-1698.
[http://dx.doi.org/10.18240/ijo.2019.11.05] [PMID: 31741856]

Li, X.; Lin, Z.; Zhang, B.; Guo, L.; Liu, S.; Li, H.; Zhang, J.; Ye, Q. β-elemene sensitizes hepatocellular carcinoma cells to oxaliplatin by preventing oxaliplatin-induced degradation of copper transporter 1. Sci. Rep., 2016, 6, 21010.
[http://dx.doi.org/10.1038/srep21010] [PMID: 26867799]

Chen, S.H.; Chang, J.Y. New insights into mechanisms of cisplatin resistance: from tumor cell to microenvironment. Int. J. Mol. Sci., 2019, 20(17), 20.
[http://dx.doi.org/10.3390/ijms20174136] [PMID: 31450627]

Porcu, C.; Antonucci, L.; Barbaro, B.; Illi, B.; Nasi, S.; Martini, M.; Licata, A.; Miele, L.; Grieco, A.; Balsano, C. Copper/MYC/CTR1 interplay: a dangerous relationship in hepatocellular carcinoma. Oncotarget, 2018, 9(10), 9325-9343.
[http://dx.doi.org/10.18632/oncotarget.24282] [PMID: 29507693]

Yang, C.S.; Chen, G.; Wu, Q. Recent scientific studies of a traditional chinese medicine, tea, on prevention of chronic diseases. J. Tradit. Complement. Med., 2014, 4(1), 17-23.
[http://dx.doi.org/10.4103/2225-4110.124326] [PMID: 24872929]

Lee, S.I.; Kim, H.J.; Boo, Y.C. Effect of green tea and (-)-epigallocatechin gallate on ethanol-induced toxicity in HepG2 cells. Phytother. Res., 2008, 22(5), 669-674.
[http://dx.doi.org/10.1002/ptr.2390] [PMID: 18350509]

Sharma, S.; Tanwar, A.; Gupta, D.K. Curcumin: An adjuvant therapeutic remedy for liver cancer. Hepatoma Res., 2016, 2, 62.
[http://dx.doi.org/10.20517/2394-5079.2015.59]

Pan, Z.; Zhuang, J.; Ji, C.; Cai, Z.; Liao, W.; Huang, Z. Curcumin inhibits hepatocellular carcinoma growth by targeting VEGF expression. Oncol. Lett., 2018, 15(4), 4821-4826.
[http://dx.doi.org/10.3892/ol.2018.7988] [PMID: 29552121]

Hu, B.; An, H.M.; Yan, X.; Zheng, J.L.; Huang, X.W.; Li, M. Traditional Chinese medicine formulation yanggan jiedu sanjie inhibits TGF-B1-induced epithelial-mesenchymal transition and metastatic potential in human hepatocarcinoma Bel-7402 cells. BMC Complement. Altern. Med., 2019, 19, 67.

Méndez-Blanco, C.; Fondevila, F.; García-Palomo, A.; González-Gallego, J.; Mauriz, J.L. Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors. Exp. Mol. Med., 2018, 50(10), 1-9.
[http://dx.doi.org/10.1038/s12276-018-0159-1] [PMID: 30315182]

Rong, L.W.; Wang, R.X.; Zheng, X.L.; Feng, X.Q.; Zhang, L.; Zhang, L.; Lin, Y.; Li, Z.P.; Wang, X. Combination of wogonin and sorafenib effectively kills human hepatocellular carcinoma cells through apoptosis potentiation and autophagy inhibition. Oncol. Lett., 2017, 13(6), 5028-5034.
[http://dx.doi.org/10.3892/ol.2017.6059] [PMID: 28599504]

Hong, M.; Almutairi, M.M.; Li, S.; Li, J. Wogonin inhibits cell cycle progression by activating the glycogen synthase kinase-3 beta in hepatocellular carcinoma. Phytomedicine, 2020, 68, 153174.
[http://dx.doi.org/10.1016/j.phymed.2020.153174] [PMID: 31991293]

Chen, Y.C.; Shen, S.C.; Lee, W.R.; Lin, H.Y.; Ko, C.H.; Shih, C.M.; Yang, L.L. Wogonin and fisetin induction of apoptosis through activation of caspase 3 cascade and alternative expression of p21 protein in hepatocellular carcinoma cells SK-HEP-1. Arch. Toxicol., 2002, 76(5-6), 351-359.
[http://dx.doi.org/10.1007/s00204-002-0346-6] [PMID: 12107653]

Hu, Z.; Yang, A.; Su, G.; Zhao, Y.; Wang, Y.; Chai, X.; Tu, P. Huaier restrains proliferative and invasive potential of human hepatoma SKHEP-1 cells partially through decreased Lamin B1 and elevated NOV. Sci. Rep., 2016, 6, 31298.
[http://dx.doi.org/10.1038/srep31298] [PMID: 27503760]

Bao, H.; Liu, P.; Jiang, K.; Zhang, X.; Xie, L.; Wang, Z.; Gong, P. Huaier polysaccharide induces apoptosis in hepatocellular carcinoma cells through p38 MAPK. Oncol. Lett., 2016, 12(2), 1058-1066.
[http://dx.doi.org/10.3892/ol.2016.4686] [PMID: 27446394]

Li, L.K.; Kuang, W.J.; Huang, Y.F.; Xie, H.H.; Chen, G.; Zhou, Q.C.; Wang, B.R.; Wan, L.H. Anti-tumor effects of Astragalus on hepatocellular carcinoma in vivo. Indian J. Pharmacol., 2012, 44(1), 78-81.
[http://dx.doi.org/10.4103/0253-7613.91872] [PMID: 22345875]

Sunwoo, Y.Y.; Lee, J.H.; Jung, H.Y.; Jung, Y.J.; Park, M.S.; Chung, Y.A.; Maeng, L.S.; Han, Y.M.; Shin, H.S.; Lee, J.; Park, S.I. Oldenlandia diffusa promotes antiproliferative and apoptotic effects in a rat hepatocellular carcinoma with liver cirrhosis. Evidence-based Complement. Altern. Med., 2015, 2015(3), 501508.

Sharma, I.; Singh, A.; Siraj, F.; Saxena, S. IL-8/CXCR1/2 signalling promotes tumor cell proliferation, invasion and vascular mimicry in glioblastoma. J. Biomed. Sci., 2018, 25(1), 62.
[http://dx.doi.org/10.1186/s12929-018-0464-y] [PMID: 30086759]

Jiang, J.W.; Chen, X.M.; Chen, X.H.; Zheng, S.S. Ginsenoside Rg3 inhibit hepatocellular carcinoma growth via intrinsic apoptotic pathway. World J. Gastroenterol., 2011, 17(31), 3605-3613.
[http://dx.doi.org/10.3748/wjg.v17.i31.3605] [PMID: 21987607]

Hu, Y.; Wang, S.; Wu, X.; Zhang, J.; Chen, R.; Chen, M.; Wang, Y. Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma. J. Ethnopharmacol., 2013, 149(3), 601-612.
[http://dx.doi.org/10.1016/j.jep.2013.07.030] [PMID: 23916858]

Ling, C.Q.; Yue, X.Q.; Ling, C. Three advantages of using traditional Chinese medicine to prevent and treat tumor. J. Integr. Med., 2014, 12(4), 331-335.
[http://dx.doi.org/10.1016/S2095-4964(14)60038-8] [PMID: 25074882]

Zeng, Z.; Xu, X.; Chen, D. Effects of Traditional Chinese Medicine on DCs Under Tumor Microenvironment; Springer: Dordrecht, 2015, pp. 55-63.
[http://dx.doi.org/10.1007/978-94-017-7405-5_5]

Liu, F.; Lou, G.; Zhang, T.; Chen, S.; Xu, J.; Xu, L.; Huang, C.; Liu, Y.; Chen, Z. Anti-metastasis traditional Chinese medicine monomer screening system based on perinucleolar compartment analysis in hepatocellular carcinoma cells. Am. J. Transl. Res., 2019, 11(6), 3555-3566.
[PMID: 31312366]